Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation. 1998

C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
Department of Surgery II, Mie University Medical School, Tsu, Japan.

The present study was designed to assess energy metabolism of steatotic grafts and to determine its relation to early graft viability. Graft biopsies were taken, and the triglyceride content was determined in 29 grafts for the assessment of steatosis. The peak aspartate aminotransferase level and the concentrations of lactate and pyruvate were strongly correlated with the triglyceride content, suggesting that steatotic grafts are more vulnerable to preservation or reperfusion injury and that glucose oxidation is inhibited postoperatively in the steatotic grafts. Ketogenesis, an alternative pathway to produce energy substrates, was not accelerated even when the steatotic grafts produced more free carnitine to enhance the beta-oxidation of fatty acids. The deterioration of energy metabolism was associated with the increase in prothrombin time ratio, hepatocyte growth factor, and hyaluronic acid that reflected graft viability. Deterioration of postperfusion energy metabolism in the steatotic grafts may be involved in the development of irreversible graft damage.

UI MeSH Term Description Entries
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses

Related Publications

C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
January 1988, Transplantation,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
August 1993, Transplantation,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
September 2006, Transplantation,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
January 1994, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
July 2003, Transplantation,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
May 2004, Transplant international : official journal of the European Society for Organ Transplantation,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
January 2010, The Journal of surgical research,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
November 1994, Medicina clinica,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
March 2020, Journal of clinical medicine,
C Miki, and K Iriyama, and D F Mirza, and A D Mayer, and J A Buckels, and H Suzuki, and P McMaster
January 1991, Journal of hepatology,
Copied contents to your clipboard!